Search Results 621-630 of 17150 for egfr

1. A Study of the Safety, Tolerability and Effectiveness of Eleclazine on Shortening the QT Interval in Adults with Long QT-3 Syndrome - Mayo Clinic

   Severe renal impairment at screening (defined as an estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73m^2, using the 4 Variable Modification of Diet ...

2. Publications - Tobias Peikert, M.D. - Mayo Clinic

   ... EGFR mutation status in lung adenocarcinomas. Sci Rep. 2017 Dec 15; 7 (1): ... EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine ...

3. A Study to Assess the Aria CV Pulmonary Hypertension System to Treat Pulmonary Arterial Hypertension - Mayo Clinic

   Current renal insufficiency as demonstrated by an eGFR \< 30 mL/min/1.73 m2 or end stage renal disease requiring chronic dialysis; d. Current diagnosis of ...

4. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

   eGFR >30 mL/min/1.73m2 during Screening. 8. Thyroid-stimulating hormone (TSH) within normal laboratory limits within the 12 weeks prior to Visit 1; if on ...

5. Nephrology and Hypertension - Clinical trials

   Learn about clinical trials being conducted at Mayo Clinic to improve the diagnosis, care and outcomes for people with kidney conditions or hypertension.

6. Publications - Joseph P. Grande, M.D., Ph.D. - Mayo Clinic

   Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma. Int J Hyperthermia. 2018 Sep; 34 (6):812-823 Epub 2017 Nov 06

7. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

   < eGFR < 60 mL/min/1.73 m^2 using SCr or cystatin C based calculation;; ≥ AST or ALT ≥ 1.5 times the upper limit of normal (ULN);; ≥ Total bilirubin ≥ 1.5 ...

8. Phase 3 Study Of Taletrectinib Vs Placebo As An Adjuvant Therapy In ROS1 Positive NSCLC (TRUST-IV) - Mayo Clinic

   Co-mutations of epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) fusion. History of other malignancies except adequately treated ...

9. Evaluation of the Zone-MPC Control Algorithm Integrated into the iAPS in Pregnant Patients with Type 1 Diabetes - Mayo Clinic

   Significant chronic kidney disease (eGFR < 60) or hemodialysis. Significant liver disease. History of adrenal insufficiency. History of abnormal TSH ...

10. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 according to the Modification of Diet in Renal Disease equation;; Evidence of significant ...